SAFEWALKER Contribution to the Rehabilitation of Older People After a Post-fall Syndrome
Launched by UNIVERSITY HOSPITAL, TOULOUSE · Jun 29, 2015
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
The post-fall syndrome is an acute functional complications of falls that affects nearly one in five elderly fallers. It combines phobia of the previous vacuum, axial and hypertension astasia abasia.
Unrecognized and untreated, it progresses to a major regressive syndrome, severe physical, psychological and social implications. Only an early rehabilitation for an early resumption of walking, prevents such a development.
The main element is to support and encourage the subject to walking. In practice, it was found that the physiotherapist can not be present daily and the duration of its in...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients hospitalized for the treatment of post-fall syndrome
- Exclusion Criteria:
- • Demential pathology (Mini Mental State \<20)
- • Parkinson's disease and other degenerative neurological disorders
- • Stroke sequelae
- • Fractures members in the previous 12 months
- • Lower limb prostheses in place within 6 months prior
- • Psychiatric disease
- • Presence of mucocutaneous lesions perineal
- • Obesity (weight \>120 kg)
About University Hospital, Toulouse
The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulouse, Midi Pyrenees, France
Patients applied
Trial Officials
Fatemeh NOURHASHEMI
Principal Investigator
University Hospital, Toulouse
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials